• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞内 Aβ 触发阿尔茨海默病 APP/PS1KI 小鼠模型胆碱能系统神经元丢失。

Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.

机构信息

Division of Molecular Psychiatry and Alzheimer Ph.D. Graduate School, Department of Psychiatry, University of Goettingen, von-Siebold-Str. 5, 37075 Goettingen, Germany.

出版信息

Neurobiol Aging. 2010 Jul;31(7):1153-63. doi: 10.1016/j.neurobiolaging.2008.07.022. Epub 2008 Sep 3.

DOI:10.1016/j.neurobiolaging.2008.07.022
PMID:18771817
Abstract

Loss of cholinergic neurons in the Nucleus Basalis of Meynert in Alzheimer's disease (AD) patients was one of the first discoveries of neuron loss in AD. Despite an intense focus on the cholinergic system in AD, the reason for this cholinergic neuron loss is yet unknown. In the present study we examined Abeta-induced pathology and neuron loss in the cholinergic system of the bigenic APP/PS1KI mouse model. Expression of the APP transgene was found in ChAT-positive neurons of motor nuclei accompanied by robust intracellular Abeta accumulation, whereas no APP expressing neurons and thus no intracellular Abeta accumulation were found in neither the forebrain or pons complexes, nor in the caudate putamen. This expression pattern was used as a model system to study the effect of intra- and extracellular Abeta accumulation on neuron loss in the cholinergic system. Stereological quantification revealed a loss of ChAT-positive neurons in APP/PS1KI mice only in the motor nuclei Mo5 and 7N accumulating intracellular Abeta. This study supports the hypothesis of intracellular Abeta accumulation as an early pathological alteration contributing to cell death in AD.

摘要

阿尔茨海默病(AD)患者基底前脑胆碱能神经元丧失是 AD 中神经元丧失的最早发现之一。尽管人们对 AD 中的胆碱能系统进行了深入研究,但这种胆碱能神经元丧失的原因仍不清楚。在本研究中,我们检查了双转基因 APP/PS1KI 小鼠模型中胆碱能系统中 Abeta 诱导的病理和神经元丧失。发现 APP 转基因在运动核中的 ChAT 阳性神经元中表达,伴随着强烈的细胞内 Abeta 积累,而在前脑或桥脑复合体中,以及尾状核壳中均未发现表达 APP 的神经元,因此也没有细胞内 Abeta 积累。这种表达模式被用作研究细胞内和细胞外 Abeta 积累对胆碱能系统中神经元丧失影响的模型系统。体视学定量显示,只有在积累细胞内 Abeta 的运动核 Mo5 和 7N 中,APP/PS1KI 小鼠中的 ChAT 阳性神经元才会丧失。这项研究支持了细胞内 Abeta 积累作为导致 AD 中细胞死亡的早期病理改变的假说。

相似文献

1
Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.细胞内 Aβ 触发阿尔茨海默病 APP/PS1KI 小鼠模型胆碱能系统神经元丢失。
Neurobiol Aging. 2010 Jul;31(7):1153-63. doi: 10.1016/j.neurobiolaging.2008.07.022. Epub 2008 Sep 3.
2
Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.在APP/PS1KI小鼠的额叶皮质中,短暂的神经元内β淀粉样蛋白而非细胞外斑块病理与神经元丢失相关。
Acta Neuropathol. 2008 Dec;116(6):647-55. doi: 10.1007/s00401-008-0451-6. Epub 2008 Oct 31.
3
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.唐氏综合征小鼠模型中App表达增加会破坏神经生长因子(NGF)的运输并导致胆碱能神经元变性。
Neuron. 2006 Jul 6;51(1):29-42. doi: 10.1016/j.neuron.2006.05.022.
4
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.APP/PS1KI小鼠模型综述:神经元内β淀粉样蛋白聚集引发轴突病变、神经元丢失和工作记忆损害。
Genes Brain Behav. 2008 Feb;7 Suppl 1:6-11. doi: 10.1111/j.1601-183X.2007.00372.x.
5
Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.在阿尔茨海默病的 APP/PS1KI 小鼠模型的大脑和脊髓中,炎症变化与神经退行性变密切相关。
Neurobiol Aging. 2010 May;31(5):747-57. doi: 10.1016/j.neurobiolaging.2008.06.011. Epub 2008 Jul 26.
6
Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.在阿尔茨海默病动物模型中,钙结合蛋白缺失神经元内的细胞内淀粉样β 积累导致淀粉样β 斑块形成。
J Alzheimers Dis. 2012;29(3):615-28. doi: 10.3233/JAD-2011-111778.
7
Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.神经元内β-淀粉样蛋白是一个主要风险因素——来自APP/PS1KI小鼠模型的新证据。
Neurodegener Dis. 2008;5(3-4):140-2. doi: 10.1159/000113684. Epub 2008 Mar 6.
8
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.阿尔茨海默病 5XFAD 小鼠模型中轴突变性和神经元内 Aβ 聚集伴随运动缺陷、神经元丢失和焦虑减轻。
Neurobiol Aging. 2012 Jan;33(1):196.e29-40. doi: 10.1016/j.neurobiolaging.2010.05.027. Epub 2010 Jul 9.
9
The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.小鼠中APP(swe)突变的存在不会增加胆碱能基底前脑神经元对神经炎症的易感性。
Neuroscience. 2004;125(3):769-76. doi: 10.1016/j.neuroscience.2004.01.050.
10
APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.APP/PS1KI双转基因小鼠出现早期突触缺陷和海马萎缩。
Acta Neuropathol. 2009 Jun;117(6):677-85. doi: 10.1007/s00401-009-0539-7. Epub 2009 Apr 23.

引用本文的文献

1
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
2
Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer's Disease-Affected Neurons: Contesting the 'Obvious'.在阿尔茨海默病受累神经元中,淀粉样前体蛋白水解途径中β淀粉样蛋白的产生停止或受到严重抑制:对“显而易见”的观点提出质疑。
Genes (Basel). 2025 Jan 2;16(1):46. doi: 10.3390/genes16010046.
3
Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer's Disease.精髓协同作用:同时给予综合应激反应抑制剂和 BACE1 和/或 BACE2 激活剂,作为阿尔茨海默病的最佳治疗策略。
Int J Mol Sci. 2024 Sep 13;25(18):9913. doi: 10.3390/ijms25189913.
4
Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.阿尔茨海默病的啮齿动物模型:过去的误解和未来的前景。
Int J Mol Sci. 2024 Jun 5;25(11):6222. doi: 10.3390/ijms25116222.
5
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.
6
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.论当前阿尔茨海默病转基因动物模型的不足:未来之路
Int J Mol Sci. 2024 Mar 4;25(5):2981. doi: 10.3390/ijms25052981.
7
A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.血脑屏障通透性的慢性增加促进外源性血源性淀粉样β1-42肽在脑内神经元内沉积,并导致小鼠模型中与阿尔茨海默病相关的认知变化。
J Alzheimers Dis. 2024;98(1):163-186. doi: 10.3233/JAD-231028.
8
Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (Aβ) by Its Targeted Degradation via Augmentation of Intra-Aβ-Cleaving Activities of BACE1 and/or BACE2.用于治疗和预防阿尔茨海默病和与衰老相关的认知能力下降的下一代治疗策略:通过增强 BACE1 和/或 BACE2 的 intra-Aβ 裂解活性,靶向性地使细胞内 Aβ (Aβ) 短暂、一次性耗尽。
Int J Mol Sci. 2023 Dec 18;24(24):17586. doi: 10.3390/ijms242417586.
9
Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer's Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions.ACH2.0视角下阿尔茨海默病及衰老相关认知衰退防治临床试验的设计原则:潜在结果、挑战与解决方案
J Alzheimers Dis Rep. 2023 Aug 28;7(1):921-955. doi: 10.3233/ADR-230037. eCollection 2023.
10
The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.阿尔茨海默病和与衰老相关的认知能力下降的淀粉样蛋白级联假说 2.0:从分子基础到有效治疗。
Int J Mol Sci. 2023 Jul 31;24(15):12246. doi: 10.3390/ijms241512246.